Page last updated: 2024-09-03

almotriptan and colforsin

almotriptan has been researched along with colforsin in 1 studies

Compound Research Comparison

Studies
(almotriptan)
Trials
(almotriptan)
Recent Studies (post-2010)
(almotriptan)
Studies
(colforsin)
Trials
(colforsin)
Recent Studies (post-2010) (colforsin)
188594213,460461,298

Protein Interaction Comparison

ProteinTaxonomyalmotriptan (IC50)colforsin (IC50)
nuclear receptor subfamily 0 group B member 1Homo sapiens (human)1.729
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.041
Adenylate cyclase type 1Homo sapiens (human)0.0955

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beleta, J; Bou, J; Domènech, T; Fernández-Forner, D; Gras, J; Heredia, A; Palacios, JM; Puig, J1

Other Studies

1 other study(ies) available for almotriptan and colforsin

ArticleYear
Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine.
    European journal of pharmacology, 2000, Dec-20, Volume: 410, Issue:1

    Topics: Animals; Cattle; Colforsin; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; HeLa Cells; Humans; Indoles; Male; Meningeal Arteries; Migraine Disorders; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Wistar; Saphenous Vein; Serotonin Receptor Agonists; Sumatriptan; Swine; Transfection; Tryptamines; Vasoconstriction; Vasoconstrictor Agents

2000